Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Max Parkin

Dr Max Parkin

Max Parkin


Honorary Senior Research Fellow

  • Clinical Trial Service and Epidemiological Studies Unit

Dr Donald Maxwell (Max) Parkin was born in 1944, and graduated summa cum laude in medicine at Edinburgh University in 1968, where he later took an MD (1985). After an early career in clinical medicine, he moved to Public Health, working in Edinburgh, Leeds, the USA (University of Michigan) before moving to Lyon, France, join the International Agency for Research on Cancer (IARC) in 1981, where he became head of the department of Descriptive Epidemiology. He remained in Lyon for 23 years, publishing extensively on cancer epidemiology, notably on geographic patterns and trends, as well as on evaluation of cancer screening.

In 2004 he returned to UK, and joined CTSU as Honorary Senior Research Fellow, and from 2005-2016 at the  the Wolfson Institute, Queen Mary University of London. He continues his association with the IARC as Senior Visiting Scientist, in order to coordinate the activities of cancer registries in Africa. The latter work is through the African Network of Cancer Registries, which was founded in 2011 with a grant from the Doris Duke cancer Foundation, USA. This project is managed through the Oxford-based NGO “INCTR Challenge Fund”

Dr Parkin is Foreign Adjunct Professor at the Karolinska Institute, Stockholm and  honorary professor at the Universities of Peking (Beijing) and Tianjin, China, and has been awarded  honorary doctorates by the University of Tampere (Finland)and Queen Mary University of London. He is a member of the editorial board of several international journals, and has published extensively, with more than 400 papers and reviews in the international scientific literature, mainly on descriptive epidemiology (international cancer patterns and trends), with a major concern for cancer registration, and in cancer prevention and control (especially the effectiveness of cancer screening).